ENTECAVIR ANHYDROUS

ENTECAVIR ANHYDROUS was reported 7098 times

ENTECAVIR ANHYDROUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GENOTYPE DRUG RESISTANCE TEST 30 0.6122
1 ASYMPTOMATIC VIRAL HEPATITIS 4 0.5714
2 PAROTID GLAND HAEMORRHAGE 6 0.4615
3 BLOOD HIV RNA DECREASED 14 0.3889
4 IVTH NERVE DISORDER 4 0.2222
5 OPTIC DISC HYPERAEMIA 5 0.2000
6 EXCESSIVE DYNAMIC AIRWAY COLLAPSE 4 0.1538
7 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 5 0.1351
8 HEPATITIS B DNA INCREASED 87 0.1291
9 ACQUIRED AMINOACIDURIA 5 0.1220
10 HEPATITIS B E ANTIGEN POSITIVE 5 0.1190
11 HIV ASSOCIATED NEPHROPATHY 6 0.1176
12 FUNGAL MYOSITIS 4 0.1143
13 HYPOCALCIURIA 4 0.0714
14 MALIGNANT ANORECTAL NEOPLASM 5 0.0667
15 HEPATITIS B SURFACE ANTIGEN POSITIVE 18 0.0657
16 HEPATITIS B DNA ASSAY POSITIVE 8 0.0625
17 PULMONARY MICROEMBOLI 6 0.0594
18 LIGAMENTITIS 4 0.0556
19 PORTAL VEIN OCCLUSION 8 0.0548
20 SCHISTOSOMIASIS 4 0.0519
21 ACUTE HEPATITIS B 16 0.0482
22 HEPATITIS B REACTIVATION 152 0.0478
23 CHRONIC HEPATITIS B 15 0.0473
24 GENOTYPE DRUG RESISTANCE TEST POSITIVE 45 0.0438
25 HEPATITIS B 254 0.0421
26 HAEMORRHAGIC CHOLECYSTITIS 5 0.0400
27 SPECIFIC GRAVITY URINE DECREASED 6 0.0390
28 OSTEOMALACIA 58 0.0375
29 VIRAL MUTATION IDENTIFIED 130 0.0353
30 HYPERPHOSPHATURIA 4 0.0342
31 RETINOPATHY HYPERTENSIVE 9 0.0297
32 MONKEYPOX 8 0.0290
33 IIIRD NERVE DISORDER 4 0.0282
34 FANCONI SYNDROME ACQUIRED 49 0.0279
35 HYPOURICAEMIA 8 0.0276
36 MITOCHONDRIAL MYOPATHY 6 0.0275
37 FANCONI SYNDROME 36 0.0254
38 AMINOACIDURIA 4 0.0252
39 HEPATIC CALCIFICATION 4 0.0242
40 HEPATITIS B VIRUS TEST POSITIVE 9 0.0236
41 PORTAL FIBROSIS 5 0.0234
42 VIRAL LOAD INCREASED 89 0.0229
43 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 6 0.0205
44 ALPHA 1 FOETOPROTEIN INCREASED 14 0.0197
45 THERAPEUTIC EMBOLISATION 6 0.0192
46 HYPOPHOSPHATAEMIC OSTEOMALACIA 5 0.0189
47 HEPATITIS B CORE ANTIBODY POSITIVE 7 0.0186
48 PLATELET DYSFUNCTION 5 0.0180
49 MULTIPLE-DRUG RESISTANCE 54 0.0174
50 HYPOPROTEINAEMIA 33 0.0174
51 HEPATOCELLULAR CARCINOMA 130 0.0171
52 RETINAL DEPIGMENTATION 5 0.0163
53 PATHOGEN RESISTANCE 142 0.0156
54 BETA 2 MICROGLOBULIN INCREASED 4 0.0153
55 MORAXELLA INFECTION 4 0.0146
56 MONOCLONAL IMMUNOGLOBULIN INCREASED 4 0.0140
57 DRUG RESISTANCE 357 0.0139
58 HEPATITIS B SURFACE ANTIBODY POSITIVE 4 0.0137
59 MORGANELLA INFECTION 4 0.0137
60 BILIARY TRACT INFECTION 8 0.0129
61 MYCOPLASMA INFECTION 10 0.0128
62 HEPATECTOMY 4 0.0128
63 HYPOPHOSPHATAEMIA 94 0.0127
64 CRYOGLOBULINAEMIA 9 0.0126
65 DISSEMINATED CRYPTOCOCCOSIS 9 0.0119
66 VASCULAR STENT STENOSIS 5 0.0119
67 RENAL TUBULAR ATROPHY 10 0.0113
68 NODULAR REGENERATIVE HYPERPLASIA 7 0.0109
69 OPTIC NEUROPATHY 22 0.0104
70 MENINGITIS CRYPTOCOCCAL 18 0.0103
71 TUMOUR INVASION 5 0.0103
72 EPISCLERITIS 7 0.0101
73 HEPATORENAL SYNDROME 17 0.0101
74 FOETAL HYPOKINESIA 7 0.0100
75 MEAN PLATELET VOLUME INCREASED 6 0.0099
76 RENAL TUBULAR INJURY 12 0.0099
77 PROCEDURAL HEADACHE 4 0.0098
78 OESOPHAGEAL VARICES HAEMORRHAGE 21 0.0097
79 STARVATION 8 0.0096
80 GASTRIC ANTRAL VASCULAR ECTASIA 5 0.0095
81 BLOOD PHOSPHORUS DECREASED 34 0.0093
82 CHONDROCALCINOSIS 6 0.0092
83 SEROSITIS 5 0.0090
84 RETINAL TOXICITY 9 0.0087
85 ARACHNOIDITIS 6 0.0087
86 VIRAEMIA 12 0.0087
87 GASTRIC VARICES 4 0.0085
88 BLOOD ALKALINE PHOSPHATASE DECREASED 8 0.0084
89 KLEBSIELLA BACTERAEMIA 8 0.0084
90 PNEUMONIA INFLUENZAL 10 0.0084
91 BLOOD BILIRUBIN UNCONJUGATED INCREASED 6 0.0083
92 IMMUNE-MEDIATED THYROIDITIS 4 0.0081
93 TESTICULAR ATROPHY 7 0.0080
94 KLEBSIELLA SEPSIS 9 0.0080
95 CRYPTOCOCCOSIS 13 0.0080
96 GASTROINTESTINAL FUNGAL INFECTION 4 0.0078
97 KLEBSIELLA TEST POSITIVE 5 0.0077
98 CRYPTOSPORIDIOSIS INFECTION 4 0.0076
99 AUTOIMMUNE HAEMOLYTIC ANAEMIA 26 0.0076
100 FOETAL HEART RATE ABNORMAL 7 0.0076
101 HEPATIC NEOPLASM MALIGNANT 16 0.0076
102 PREGNANCY ON CONTRACEPTIVE 11 0.0075
103 NEONATAL RESPIRATORY DISTRESS 7 0.0074
104 PORTAL VEIN THROMBOSIS 24 0.0074
105 RENAL TUBULAR ACIDOSIS 16 0.0073
106 LIVER TRANSPLANT REJECTION 13 0.0072
107 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 12 0.0072
108 MALARIA 5 0.0071
109 RENAL TUBULAR DYSFUNCTION 4 0.0071
110 ILEAL ULCER 7 0.0069
111 ALANINE AMINOTRANSFERASE DECREASED 5 0.0069
112 SYPHILIS 5 0.0069
113 CAMPYLOBACTER GASTROENTERITIS 4 0.0067
114 COMA HEPATIC 5 0.0067
115 HEPATIC ENCEPHALOPATHY 62 0.0066
116 SYSTEMIC INFECTION 11 0.0066
117 CHOLANGITIS ACUTE 5 0.0066
118 LIVER TRANSPLANT 24 0.0066
119 IMMUNE-MEDIATED LUNG DISEASE 12 0.0066
120 ADENOCARCINOMA GASTRIC 6 0.0065
121 BLOOD CHLORIDE INCREASED 11 0.0064
122 MIXED LIVER INJURY 19 0.0063
123 HERPES ZOSTER DISSEMINATED 5 0.0062
124 CYTOMEGALOVIRUS CHORIORETINITIS 12 0.0061
125 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 14 0.0060
126 GLYCOSURIA 8 0.0059
127 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 7 0.0058
128 HEPATIC FIBROSIS 20 0.0058
129 BLOOD BICARBONATE DECREASED 11 0.0058
130 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 19 0.0057
131 POLYOMAVIRUS VIRAEMIA 6 0.0056
132 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 7 0.0055
133 OBSTRUCTION GASTRIC 7 0.0054
134 CHOLANGIOCARCINOMA 8 0.0054
135 PACKED RED BLOOD CELL TRANSFUSION 7 0.0053
136 HYPOALBUMINAEMIA 41 0.0053
137 CANCER SURGERY 5 0.0052
138 FEBRILE INFECTION 6 0.0051
139 EXPOSURE VIA BODY FLUID 4 0.0051
140 HEPATITIS E 8 0.0051
141 TRANSPLANT DYSFUNCTION 9 0.0050
142 PROCEDURAL NAUSEA 4 0.0050
143 VARICES OESOPHAGEAL 15 0.0050
144 IMMUNE-MEDIATED HEPATITIS 10 0.0049
145 HEPATIC FAILURE 147 0.0049
146 HEPATIC CIRRHOSIS 91 0.0048
147 HYDROTHORAX 4 0.0048
148 FUNGAL SEPSIS 4 0.0048
149 COVID-19 IMMUNISATION 4 0.0048
150 CYTOMEGALOVIRUS INFECTION REACTIVATION 21 0.0047
151 PARAINFLUENZAE VIRUS INFECTION 7 0.0046
152 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 10 0.0045
153 CANDIDA SEPSIS 4 0.0045
154 PROTEIN URINE 4 0.0044
155 LYMPHOCYTE COUNT DECREASED 77 0.0044
156 LIVER ABSCESS 14 0.0043
157 CHRONIC SPONTANEOUS URTICARIA 5 0.0043
158 PRURITUS ALLERGIC 5 0.0043
159 BILIRUBIN CONJUGATED INCREASED 10 0.0043
160 HYPOCHLORAEMIA 5 0.0043
161 RENAL TUBULAR DISORDER 12 0.0043
162 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 4 0.0042
163 BILE DUCT STENOSIS 5 0.0042
164 GRANULOMATOSIS WITH POLYANGIITIS 5 0.0041
165 HYPERURICAEMIA 17 0.0041
166 VIROLOGIC FAILURE 22 0.0041
167 GENE MUTATION 8 0.0040
168 KIDNEY FIBROSIS 7 0.0040
169 METABOLIC ENCEPHALOPATHY 12 0.0040
170 HEPATIC NEOPLASM 13 0.0040
171 MEAN CELL VOLUME DECREASED 6 0.0039
172 BONE MARROW OEDEMA 4 0.0039
173 BLOOD HIV RNA INCREASED 7 0.0039
174 BLOOD CREATINE INCREASED 17 0.0038
175 ENCEPHALITIS AUTOIMMUNE 5 0.0038
176 HYDROCELE 4 0.0038
177 GALLBLADDER ENLARGEMENT 4 0.0037
178 ACUTE LEUKAEMIA 6 0.0037
179 VENOOCCLUSIVE LIVER DISEASE 18 0.0036
180 BLOOD PRESSURE SYSTOLIC ABNORMAL 9 0.0036
181 SPLENECTOMY 4 0.0034
182 PROCALCITONIN INCREASED 4 0.0034
183 PROTEIN URINE PRESENT 17 0.0034
184 SECONDARY IMMUNODEFICIENCY 4 0.0033
185 BLOOD URIC ACID INCREASED 19 0.0033
186 GLOMERULONEPHRITIS 8 0.0033
187 PALLIATIVE CARE 5 0.0033
188 ASCITES 96 0.0033
189 LYMPHOCYTOSIS 7 0.0032
190 CREATININE RENAL CLEARANCE DECREASED 13 0.0032
191 OTOTOXICITY 6 0.0032
192 PORTAL HYPERTENSION 10 0.0032
193 FRACTURED SACRUM 4 0.0032
194 STEM CELL TRANSPLANT 8 0.0032
195 NOSOCOMIAL INFECTION 7 0.0032
196 GLUCOSE URINE PRESENT 4 0.0031
197 PLATELET TRANSFUSION 4 0.0031
198 OPTIC ATROPHY 5 0.0031
199 BK VIRUS INFECTION 10 0.0030
200 CYTOKINE RELEASE SYNDROME 59 0.0029
201 NEPHROPATHY TOXIC 33 0.0029
202 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 22 0.0029
203 FIXED ERUPTION 5 0.0029
204 ABORTION INDUCED 27 0.0029
205 IMMUNE THROMBOCYTOPENIA 13 0.0028
206 BLOOD BILIRUBIN INCREASED 76 0.0028
207 CYTOMEGALOVIRUS TEST POSITIVE 5 0.0028
208 COVID-19 PNEUMONIA 33 0.0028
209 HYPERPHOSPHATAEMIA 6 0.0028
210 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 4 0.0028
211 HYPOCALCAEMIA 52 0.0027
212 DIFFUSE LARGE B-CELL LYMPHOMA 21 0.0027
213 BENIGN PROSTATIC HYPERPLASIA 14 0.0027
214 NEUTROPHIL COUNT DECREASED 110 0.0027
215 MYELOPATHY 5 0.0026
216 FUNGAL PERITONITIS 4 0.0026
217 PROTEINURIA 50 0.0026
218 BACTERAEMIA 31 0.0026
219 MYELITIS 4 0.0026
220 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
221 ACUTE HEPATIC FAILURE 35 0.0026
222 JAUNDICE CHOLESTATIC 9 0.0025
223 HEPATIC FUNCTION ABNORMAL 95 0.0025
224 OCULAR ICTERUS 11 0.0025
225 TRANSPLANT REJECTION 20 0.0025
226 RENAL TRANSPLANT 9 0.0025
227 STRONGYLOIDIASIS 4 0.0025
228 FEBRILE NEUTROPENIA 163 0.0025
229 VARICELLA ZOSTER VIRUS INFECTION 5 0.0024
230 HYPERPARATHYROIDISM SECONDARY 6 0.0024
231 MYOCARDIAL NECROSIS MARKER INCREASED 4 0.0024
232 AUTOIMMUNE THYROIDITIS 9 0.0024
233 GLOMERULAR FILTRATION RATE DECREASED 29 0.0024
234 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 5 0.0023
235 YELLOW SKIN 11 0.0023
236 HAEMOLYTIC ANAEMIA 21 0.0023
237 HYPOPITUITARISM 4 0.0023
238 TRANSAMINASES INCREASED 51 0.0023
239 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4 0.0023
240 HYPOKALAEMIA 103 0.0022
241 COMPLICATIONS OF TRANSPLANTED KIDNEY 5 0.0022
242 BRONCHOPULMONARY ASPERGILLOSIS 17 0.0022
243 JAUNDICE 59 0.0022
244 PNEUMONIA BACTERIAL 20 0.0022
245 IMMUNE-MEDIATED ENTEROCOLITIS 8 0.0022
246 CYTOMEGALOVIRUS INFECTION 36 0.0022
247 ADENOCARCINOMA OF COLON 4 0.0021
248 INTRA-ABDOMINAL HAEMORRHAGE 5 0.0021
249 ALANINE AMINOTRANSFERASE INCREASED 128 0.0021
250 METASTASES TO LUNG 24 0.0021
251 HEPATIC MASS 4 0.0021
252 ESCHERICHIA SEPSIS 6 0.0021
253 PLATELET COUNT DECREASED 220 0.0021
254 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
255 EARLY SATIETY 4 0.0021
256 AGRANULOCYTOSIS 38 0.0020
257 VIRAL INFECTION 68 0.0020
258 PYELONEPHRITIS ACUTE 4 0.0020
259 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
260 AUTOIMMUNE HEPATITIS 14 0.0020
261 THYROIDITIS 6 0.0020
262 LUNG ADENOCARCINOMA 6 0.0020
263 HIV INFECTION 6 0.0020
264 CHOLESTASIS 38 0.0020
265 UPPER GASTROINTESTINAL HAEMORRHAGE 33 0.0020
266 ABDOMINAL INFECTION 5 0.0020
267 NEUTROPHIL COUNT INCREASED 20 0.0020
268 DRUG-INDUCED LIVER INJURY 61 0.0019
269 HYPERPARATHYROIDISM 4 0.0019
270 EUGLYCAEMIC DIABETIC KETOACIDOSIS 8 0.0019
271 HYPERBILIRUBINAEMIA 20 0.0019
272 HYPERSENSITIVITY VASCULITIS 5 0.0019
273 CYTOPENIA 23 0.0019
274 RADIATION PNEUMONITIS 4 0.0019
275 PLASMA CELL MYELOMA RECURRENT 6 0.0018
276 NORMAL NEWBORN 10 0.0018
277 GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0018
278 NEPHRITIS 6 0.0018
279 PROCTITIS 5 0.0018
280 PNEUMONIA FUNGAL 7 0.0018
281 CHRONIC GASTRITIS 4 0.0018
282 SEPTIC SHOCK 77 0.0018
283 B-CELL LYMPHOMA 6 0.0018
284 RENAL CYST 14 0.0018
285 OXYGEN SATURATION ABNORMAL 5 0.0018
286 TUMOUR HAEMORRHAGE 5 0.0018
287 BLOOD CREATININE INCREASED 114 0.0017
288 BLOOD MAGNESIUM DECREASED 15 0.0017
289 HEPATIC CYTOLYSIS 22 0.0017
290 LICHEN PLANUS 4 0.0017
291 ENTERITIS 11 0.0017
292 LIPASE INCREASED 13 0.0017
293 MULTIPLE ORGAN DYSFUNCTION SYNDROME 48 0.0017
294 PNEUMOCYSTIS JIROVECII PNEUMONIA 17 0.0017
295 PLEURISY 10 0.0017
296 ASPARTATE AMINOTRANSFERASE INCREASED 89 0.0017
297 HYPOGAMMAGLOBULINAEMIA 11 0.0017
298 HEPATITIS C 20 0.0017
299 HYPERPYREXIA 7 0.0017
300 OSTEOPOROSIS 68 0.0017
301 HEPATITIS 42 0.0016
302 SPLENOMEGALY 19 0.0016
303 FLANK PAIN 15 0.0016
304 BLOOD CREATININE DECREASED 5 0.0016
305 PROTEIN TOTAL DECREASED 6 0.0016
306 SYSTEMIC CANDIDA 4 0.0016
307 POLYNEUROPATHY 19 0.0016
308 METASTASES TO PERITONEUM 4 0.0016
309 RENAL IMPAIRMENT 133 0.0016
310 LABYRINTHITIS 4 0.0016
311 HEPATIC CANCER 38 0.0016
312 BLOOD PRESSURE DIASTOLIC ABNORMAL 4 0.0016
313 LEUKOPENIA 78 0.0016
314 SUSPECTED OFF LABEL USE 7 0.0015
315 RHINOVIRUS INFECTION 6 0.0015
316 HERPES SIMPLEX 10 0.0015
317 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 9 0.0015
318 MYOPATHY 13 0.0015
319 MYELOSUPPRESSION 54 0.0015
320 HYPERLACTACIDAEMIA 4 0.0015
321 WHITE BLOOD CELL COUNT DECREASED 160 0.0015
322 RECURRENT CANCER 6 0.0015
323 DEMYELINATION 6 0.0015
324 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 12 0.0015
325 APLASIA PURE RED CELL 5 0.0015
326 BLOOD CREATININE ABNORMAL 5 0.0014
327 HYPOMAGNESAEMIA 20 0.0014
328 LUNG CONSOLIDATION 4 0.0014
329 PERIORBITAL SWELLING 8 0.0014
330 HEPATOCELLULAR INJURY 20 0.0014
331 BLOOD ALKALINE PHOSPHATASE INCREASED 35 0.0014
332 ANURIA 12 0.0014
333 BLOOD ALBUMIN DECREASED 11 0.0014
334 KLEBSIELLA INFECTION 7 0.0014
335 FEMORAL NECK FRACTURE 7 0.0014
336 THROMBOCYTOPENIA 151 0.0013
337 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
338 HEPATITIS FULMINANT 4 0.0013
339 METABOLIC ACIDOSIS 43 0.0013
340 ESCHERICHIA INFECTION 11 0.0013
341 BLOOD PRESSURE SYSTOLIC INCREASED 26 0.0013
342 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
343 STATUS EPILEPTICUS 15 0.0013
344 BLOOD LACTATE DEHYDROGENASE INCREASED 21 0.0013
345 BLOOD CREATINE PHOSPHOKINASE INCREASED 38 0.0013
346 EMERGENCY CARE 4 0.0013
347 FIBROSIS 4 0.0013
348 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
349 HYPERTRANSAMINASAEMIA 9 0.0013
350 PSEUDOMONAS INFECTION 11 0.0013
351 SUSPECTED COUNTERFEIT PRODUCT 5 0.0013
352 LIVER INJURY 31 0.0013
353 ENCEPHALOPATHY 31 0.0013
354 VENTRICULAR FIBRILLATION 14 0.0013
355 CHOLECYSTITIS 15 0.0013
356 HEPATOTOXICITY 28 0.0013
357 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12 0.0013
358 OSTEOPENIA 19 0.0013
359 TUMOUR LYSIS SYNDROME 11 0.0012
360 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
361 HEPATITIS ACUTE 8 0.0012
362 OTITIS MEDIA 4 0.0012
363 ORGANISING PNEUMONIA 6 0.0012
364 HYPERNATRAEMIA 6 0.0012
365 HYDRONEPHROSIS 9 0.0012
366 HYPERAMMONAEMIA 6 0.0012
367 RHABDOMYOLYSIS 50 0.0012
368 ANXIETY DISORDER 4 0.0012
369 SINUS TACHYCARDIA 17 0.0012
370 HYPERTRIGLYCERIDAEMIA 7 0.0012
371 ACUTE RESPIRATORY FAILURE 23 0.0012
372 NEUTROPENIA 162 0.0012
373 DRUG TOLERANCE 6 0.0012
374 HEPATIC CYST 4 0.0012
375 TACHYPNOEA 16 0.0012
376 GAMMA-GLUTAMYLTRANSFERASE INCREASED 26 0.0012
377 RASH MACULO-PAPULAR 26 0.0012
378 TENDERNESS 12 0.0012
379 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
380 BLOOD LACTIC ACID INCREASED 6 0.0011
381 SERUM FERRITIN INCREASED 6 0.0011
382 DEPRESSIVE SYMPTOM 4 0.0011
383 VITAMIN D DEFICIENCY 11 0.0011
384 HAEMORRHAGE SUBCUTANEOUS 4 0.0011
385 ANAL FISTULA 6 0.0011
386 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
387 COMPRESSION FRACTURE 6 0.0011
388 CAESAREAN SECTION 13 0.0011
389 GASTROINTESTINAL INFECTION 10 0.0011
390 GINGIVITIS 6 0.0011
391 LACTIC ACIDOSIS 36 0.0011
392 RENAL INJURY 33 0.0011
393 HICCUPS 9 0.0011
394 AMYLASE INCREASED 4 0.0011
395 HYPERKALAEMIA 38 0.0011
396 NEPHROGENIC ANAEMIA 5 0.0011
397 ARTHRITIS INFECTIVE 5 0.0011
398 BLOOD CALCIUM DECREASED 12 0.0011
399 ACUTE KIDNEY INJURY 162 0.0011
400 GRANULOCYTOPENIA 6 0.0011
401 HYPERCALCAEMIA 13 0.0011
402 CARDIAC TAMPONADE 5 0.0011
403 CARDIAC FAILURE ACUTE 7 0.0010
404 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
405 GASTROINTESTINAL TOXICITY 5 0.0010
406 ENTEROCOLITIS 6 0.0010
407 LYMPHOMA 16 0.0010
408 ELECTROLYTE IMBALANCE 12 0.0010
409 VASCULITIS 12 0.0010
410 PLASMA CELL MYELOMA 40 0.0010
411 BONE PAIN 60 0.0010
412 STAPHYLOCOCCAL SEPSIS 5 0.0010
413 MYOSITIS 9 0.0010
414 INGUINAL HERNIA 6 0.0010
415 GRAFT VERSUS HOST DISEASE 7 0.0010
416 CACHEXIA 5 0.0010
417 OLIGURIA 6 0.0010
418 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
419 CHRONIC KIDNEY DISEASE 73 0.0010
420 COAGULOPATHY 16 0.0010
421 CONGESTIVE CARDIOMYOPATHY 4 0.0010
422 HAEMATOCRIT DECREASED 19 0.0010
423 PLEURAL EFFUSION 58 0.0010
424 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 22 0.0009
425 HEPATIC PAIN 4 0.0009
426 CHROMATURIA 21 0.0009
427 ASPERGILLUS INFECTION 6 0.0009
428 PROCEDURAL COMPLICATION 7 0.0009
429 INTERSTITIAL LUNG DISEASE 44 0.0009
430 DRUG LEVEL INCREASED 15 0.0009
431 DRUG ERUPTION 16 0.0009
432 LIVER DISORDER 40 0.0009
433 NECROSIS 5 0.0009
434 GASTRIC ULCER 17 0.0009
435 RESPIRATORY FAILURE 64 0.0009
436 DISEASE COMPLICATION 4 0.0009
437 HERPES VIRUS INFECTION 5 0.0009
438 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
439 PETECHIAE 9 0.0009
440 SEPSIS 96 0.0009
441 TRANSFUSION 9 0.0009
442 NEUROTOXICITY 15 0.0009
443 HYPOXIA 30 0.0009
444 HEPATIC ENZYME INCREASED 58 0.0008
445 DUODENAL ULCER 6 0.0008
446 LYMPHOPENIA 12 0.0008
447 COLITIS 32 0.0008
448 GESTATIONAL DIABETES 4 0.0008
449 ANHEDONIA 22 0.0008
450 LIVE BIRTH 7 0.0008
451 BONE MARROW FAILURE 17 0.0008
452 KIDNEY TRANSPLANT REJECTION 4 0.0008
453 HEPATITIS CHOLESTATIC 5 0.0008
454 HUMERUS FRACTURE 4 0.0008
455 ANAEMIA 158 0.0008
456 ENTEROCOCCAL INFECTION 4 0.0008
457 THROMBOTIC MICROANGIOPATHY 8 0.0008
458 PARKINSONISM 8 0.0008
459 HYPERVOLAEMIA 4 0.0008
460 PNEUMONITIS 22 0.0008
461 PULMONARY MASS 12 0.0008
462 MALNUTRITION 9 0.0008
463 HYPONATRAEMIA 45 0.0008
464 SPINAL OSTEOARTHRITIS 7 0.0008
465 ERYSIPELAS 4 0.0008
466 HAEMATEMESIS 20 0.0008
467 EYELID PTOSIS 8 0.0008
468 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 4 0.0008
469 ACIDOSIS 6 0.0008
470 AMMONIA INCREASED 4 0.0008
471 GOUT 14 0.0008
472 PERICARDIAL EFFUSION 18 0.0008
473 CEREBRAL ISCHAEMIA 4 0.0008
474 HAEMOLYSIS 6 0.0008
475 MELAENA 17 0.0008
476 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
477 FOETAL DEATH 4 0.0008
478 ANGINA UNSTABLE 5 0.0008
479 TREATMENT NONCOMPLIANCE 42 0.0008
480 MALABSORPTION 4 0.0008
481 APLASTIC ANAEMIA 4 0.0008
482 IRON DEFICIENCY ANAEMIA 7 0.0008
483 FULL BLOOD COUNT ABNORMAL 8 0.0008
484 MENTAL STATUS CHANGES 21 0.0008
485 ATRIAL FLUTTER 6 0.0008
486 BLOOD DISORDER 6 0.0007
487 SPINAL FRACTURE 15 0.0007
488 PYREXIA 259 0.0007
489 SQUAMOUS CELL CARCINOMA 7 0.0007
490 ANAL ABSCESS 4 0.0007
491 ADRENAL INSUFFICIENCY 9 0.0007
492 POSTOPERATIVE WOUND INFECTION 5 0.0007
493 SHOCK HAEMORRHAGIC 6 0.0007
494 HAEMATOTOXICITY 7 0.0007
495 BODY TEMPERATURE INCREASED 15 0.0007
496 GINGIVAL BLEEDING 10 0.0007
497 JAW DISORDER 4 0.0007
498 WHITE BLOOD CELL COUNT INCREASED 28 0.0007
499 RESPIRATORY TRACT INFECTION 19 0.0007
500 NEPHROTIC SYNDROME 5 0.0007
501 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
502 ENCEPHALITIS 5 0.0007
503 LIVER FUNCTION TEST ABNORMAL 21 0.0007
504 BLOOD UREA INCREASED 12 0.0007
505 RENAL FAILURE 95 0.0007
506 RENAL TUBULAR NECROSIS 7 0.0007
507 CANDIDA INFECTION 12 0.0007
508 LUNG INFECTION 11 0.0007
509 MATERNAL EXPOSURE DURING PREGNANCY 63 0.0007
510 CHOLECYSTITIS ACUTE 4 0.0007
511 THERAPY PARTIAL RESPONDER 11 0.0007
512 SUBDURAL HAEMATOMA 10 0.0007
513 EMPHYSEMA 7 0.0007
514 VISUAL FIELD DEFECT 5 0.0007
515 HAEMOGLOBIN DECREASED 71 0.0007
516 PREMATURE DELIVERY 11 0.0007
517 DERMATITIS BULLOUS 5 0.0007
518 EYELID OEDEMA 8 0.0007
519 URINE OUTPUT DECREASED 6 0.0007
520 HYPERGLYCAEMIA 25 0.0007
521 GASTRITIS 18 0.0007
522 MOUTH HAEMORRHAGE 5 0.0007
523 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
524 IMMUNOSUPPRESSION 6 0.0007
525 LUNG INFILTRATION 6 0.0007
526 PERITONITIS 14 0.0007
527 TREATMENT FAILURE 56 0.0007
528 NEUROPATHY PERIPHERAL 64 0.0007
529 PNEUMONIA 217 0.0007
530 METASTASES TO BONE 11 0.0007
531 PROTHROMBIN TIME PROLONGED 4 0.0007
532 RENAL DISORDER 31 0.0007
533 RED BLOOD CELL COUNT DECREASED 19 0.0007
534 PEMPHIGOID 5 0.0007
535 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 17 0.0007
536 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
537 ECONOMIC PROBLEM 10 0.0007
538 DISEASE PROGRESSION 78 0.0007
539 DERMATITIS ACNEIFORM 4 0.0007
540 PERICARDITIS 11 0.0007
541 DRUG INTERACTION 103 0.0006
542 LARYNGEAL OEDEMA 4 0.0006
543 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
544 GASTROINTESTINAL HAEMORRHAGE 54 0.0006
545 MUSCULOSKELETAL CHEST PAIN 10 0.0006
546 CHOLANGITIS 4 0.0006
547 TASTE DISORDER 13 0.0006
548 BLINDNESS UNILATERAL 9 0.0006
549 MULTI-ORGAN FAILURE 11 0.0006
550 CARDIAC FAILURE 51 0.0006
551 LOW BIRTH WEIGHT BABY 5 0.0006
552 PANCYTOPENIA 35 0.0006
553 SKIN INFECTION 7 0.0006
554 GASTROENTERITIS 9 0.0006
555 ISCHAEMIC STROKE 11 0.0006
556 BLOOD POTASSIUM INCREASED 10 0.0006
557 PLATELET COUNT INCREASED 8 0.0006
558 NEOPLASM 7 0.0006
559 MULTIPLE FRACTURES 10 0.0006
560 GASTRIC HAEMORRHAGE 7 0.0006
561 LIVER FUNCTION TEST INCREASED 13 0.0006
562 END STAGE RENAL DISEASE 11 0.0006
563 SPINAL PAIN 7 0.0006
564 HAEMODIALYSIS 5 0.0006
565 SKIN PLAQUE 5 0.0006
566 HEPATIC STEATOSIS 11 0.0006
567 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
568 HYPOPHAGIA 15 0.0006
569 HYPERLIPIDAEMIA 7 0.0006
570 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
571 PERIPHERAL COLDNESS 8 0.0006
572 PANCREATITIS ACUTE 13 0.0006
573 CEREBRAL INFARCTION 14 0.0006
574 MOUTH ULCERATION 12 0.0006
575 SMALL INTESTINAL OBSTRUCTION 7 0.0006
576 DECREASED APPETITE 132 0.0006
577 PNEUMOTHORAX 9 0.0006
578 PHARYNGITIS 7 0.0006
579 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 40 0.0006
580 NEUTROPENIC SEPSIS 4 0.0006
581 HERPES ZOSTER 32 0.0006
582 DERMATITIS ALLERGIC 7 0.0006
583 DECREASED ACTIVITY 6 0.0006
584 PRODUCT PRESCRIBING ISSUE 12 0.0006
585 C-REACTIVE PROTEIN INCREASED 20 0.0005
586 INTENTIONAL PRODUCT USE ISSUE 48 0.0005
587 COVID-19 96 0.0005
588 HOSPITALISATION 84 0.0005
589 DISEASE RECURRENCE 26 0.0005
590 FULL BLOOD COUNT DECREASED 11 0.0005
591 BONE DENSITY DECREASED 17 0.0005
592 HAEMOPTYSIS 15 0.0005
593 KETOACIDOSIS 4 0.0005
594 FACE OEDEMA 9 0.0005
595 SOPOR 7 0.0005
596 ARRHYTHMIA 25 0.0005
597 INFECTION 76 0.0005
598 DERMATITIS 11 0.0005
599 HYPERTHERMIA 4 0.0005
600 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
601 LOWER LIMB FRACTURE 10 0.0005
602 UPPER RESPIRATORY TRACT INFECTION 24 0.0005
603 HYPERCHOLESTEROLAEMIA 5 0.0005
604 SKIN FISSURES 10 0.0005
605 POOR QUALITY SLEEP 11 0.0005
606 PANCREATITIS 27 0.0005
607 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
608 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
609 LIGAMENT SPRAIN 5 0.0005
610 ABDOMINAL DISTENSION 52 0.0005
611 HAEMATURIA 17 0.0005
612 MYASTHENIA GRAVIS 4 0.0005
613 NO THERAPEUTIC RESPONSE 6 0.0005
614 SUBARACHNOID HAEMORRHAGE 5 0.0005
615 OFF LABEL USE 429 0.0005
616 MUSCLE SPASTICITY 6 0.0005
617 SPINAL OPERATION 6 0.0005
618 VENTRICULAR TACHYCARDIA 8 0.0005
619 WEIGHT FLUCTUATION 5 0.0005
620 SUDDEN DEATH 5 0.0005
621 HYPOTHYROIDISM 15 0.0005
622 IMMUNODEFICIENCY 7 0.0005
623 FACIAL PARALYSIS 4 0.0005
624 THERAPY NON-RESPONDER 21 0.0005
625 SKIN HYPERPIGMENTATION 4 0.0005
626 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
627 CHILLS 54 0.0005
628 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
629 PRODUCT COMMUNICATION ISSUE 4 0.0005
630 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
631 PURPURA 4 0.0005
632 LYMPHADENOPATHY 16 0.0005
633 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
634 INTESTINAL OBSTRUCTION 17 0.0005
635 THERAPY INTERRUPTED 32 0.0004
636 ASTHENIA 167 0.0004
637 RASH PRURITIC 24 0.0004
638 REBOUND EFFECT 5 0.0004
639 ABSCESS 7 0.0004
640 INTERNAL HAEMORRHAGE 5 0.0004
641 RIB FRACTURE 9 0.0004
642 MYOCARDITIS 5 0.0004
643 HAEMATOCHEZIA 24 0.0004
644 SHOCK 10 0.0004
645 RESPIRATORY DISTRESS 12 0.0004
646 BLOOD POTASSIUM DECREASED 13 0.0004
647 FOETAL EXPOSURE DURING PREGNANCY 35 0.0004
648 MALIGNANT NEOPLASM PROGRESSION 44 0.0004
649 ERYTHEMA MULTIFORME 4 0.0004
650 LUNG DISORDER 21 0.0004
651 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
652 LEUKAEMIA 4 0.0004
653 GENERAL PHYSICAL HEALTH DETERIORATION 49 0.0004
654 FRACTURE 8 0.0004
655 PULMONARY FIBROSIS 8 0.0004
656 CELLULITIS 21 0.0004
657 STOMATITIS 25 0.0004
658 FREQUENT BOWEL MOVEMENTS 11 0.0004
659 HEPATOMEGALY 4 0.0004
660 BODY TEMPERATURE DECREASED 4 0.0004
661 GENERALISED OEDEMA 5 0.0004
662 EPISTAXIS 30 0.0004
663 CONDITION AGGRAVATED 121 0.0004
664 DIARRHOEA 256 0.0004
665 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
666 MUSCULAR WEAKNESS 45 0.0004
667 TACHYCARDIA 35 0.0004
668 MOTOR DYSFUNCTION 4 0.0004
669 CEREBRAL HAEMORRHAGE 14 0.0004
670 DEVICE RELATED INFECTION 6 0.0004
671 HYPOTENSION 78 0.0004
672 HAEMATOMA 10 0.0004
673 INTENTIONAL DOSE OMISSION 11 0.0004
674 BASAL CELL CARCINOMA 6 0.0004
675 CONTUSION 37 0.0004
676 PULMONARY OEDEMA 17 0.0004
677 IMMUNE SYSTEM DISORDER 5 0.0004
678 COMA 18 0.0004
679 HYPERTENSION 80 0.0004
680 BODY HEIGHT DECREASED 4 0.0004
681 ACUTE MYOCARDIAL INFARCTION 11 0.0004
682 QUALITY OF LIFE DECREASED 5 0.0004
683 ATRIAL FIBRILLATION 36 0.0004
684 FOOT FRACTURE 7 0.0004
685 DIABETES MELLITUS 28 0.0004
686 OESOPHAGITIS 4 0.0004
687 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
688 ASPIRATION 4 0.0004
689 COGNITIVE DISORDER 17 0.0004
690 CONSTIPATION 79 0.0004
691 FOOT DEFORMITY 4 0.0004
692 FUNGAL INFECTION 12 0.0004
693 BLOOD TEST ABNORMAL 5 0.0004
694 HEMIPARESIS 6 0.0004
695 MITRAL VALVE INCOMPETENCE 4 0.0004
696 DYSURIA 13 0.0004
697 NERVOUS SYSTEM DISORDER 11 0.0004
698 MYOCARDIAL ISCHAEMIA 4 0.0004
699 ERECTILE DYSFUNCTION 9 0.0004
700 ABORTION SPONTANEOUS 14 0.0003
701 URINARY TRACT INFECTION 59 0.0003
702 HYPERTHYROIDISM 5 0.0003
703 DYSPNOEA EXERTIONAL 13 0.0003
704 FEEDING DISORDER 7 0.0003
705 HYPOKINESIA 5 0.0003
706 PRODUCT USE IN UNAPPROVED INDICATION 85 0.0003
707 DEATH 295 0.0003
708 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
709 ATAXIA 4 0.0003
710 BACK PAIN 78 0.0003
711 COLON CANCER 5 0.0003
712 CHOLELITHIASIS 11 0.0003
713 PREMATURE BABY 10 0.0003
714 INFLUENZA 37 0.0003
715 LEUKOCYTOSIS 6 0.0003
716 ABDOMINAL PAIN 77 0.0003
717 DEHYDRATION 44 0.0003
718 THERAPEUTIC RESPONSE DECREASED 20 0.0003
719 EATING DISORDER 7 0.0003
720 BLOOD PRESSURE INCREASED 50 0.0003
721 NEPHROLITHIASIS 15 0.0003
722 TYPE 2 DIABETES MELLITUS 11 0.0003
723 HAEMORRHAGE 34 0.0003
724 PHARYNGEAL OEDEMA 5 0.0003
725 FEELING COLD 9 0.0003
726 ILEUS 4 0.0003
727 BACTERIAL INFECTION 6 0.0003
728 ACUTE MYELOID LEUKAEMIA 5 0.0003
729 OXYGEN SATURATION DECREASED 18 0.0003
730 OEDEMA PERIPHERAL 39 0.0003
731 SECRETION DISCHARGE 4 0.0003
732 BRAIN FOG 5 0.0003
733 PERIPHERAL SWELLING 49 0.0003
734 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
735 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
736 GASTRIC CANCER 8 0.0003
737 MUSCLE ATROPHY 4 0.0003
738 OEDEMA 17 0.0003
739 POST PROCEDURAL COMPLICATION 6 0.0003
740 MYALGIA 53 0.0003
741 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
742 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
743 RENAL FAILURE ACUTE 13 0.0003
744 ABDOMINAL PAIN UPPER 63 0.0003
745 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
746 MUCOSAL INFLAMMATION 8 0.0003
747 SARS-COV-2 TEST POSITIVE 4 0.0003
748 CATARACT 18 0.0003
749 UPPER LIMB FRACTURE 6 0.0003
750 RESPIRATORY DISORDER 9 0.0003
751 WEIGHT DECREASED 83 0.0003
752 LIMB INJURY 8 0.0003
753 EPILEPSY 9 0.0003
754 CIRCULATORY COLLAPSE 5 0.0003
755 GAIT DISTURBANCE 56 0.0003
756 CARDIAC ARREST 24 0.0003
757 INFLAMMATION 15 0.0003
758 MUSCULOSKELETAL DISCOMFORT 5 0.0003
759 EXPOSURE DURING PREGNANCY 18 0.0003
760 FATIGUE 225 0.0003
761 DELIRIUM 10 0.0003
762 NEURALGIA 7 0.0003
763 INFUSION RELATED REACTION 19 0.0003
764 CARDIAC FAILURE CONGESTIVE 23 0.0003
765 RASH MACULAR 10 0.0003
766 PULMONARY EMBOLISM 27 0.0003
767 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
768 FLATULENCE 16 0.0003
769 DIALYSIS 4 0.0003
770 UNEVALUABLE EVENT 21 0.0003
771 GASTROENTERITIS VIRAL 5 0.0003
772 TOOTHACHE 5 0.0003
773 DRUG INEFFECTIVE 362 0.0003
774 BLOOD PRESSURE DECREASED 18 0.0003
775 TOOTH DISORDER 6 0.0003
776 HYPOAESTHESIA 40 0.0003
777 TOXICITY TO VARIOUS AGENTS 45 0.0003
778 POLLAKIURIA 11 0.0003
779 OROPHARYNGEAL PAIN 24 0.0003
780 ANKLE FRACTURE 4 0.0003
781 FEMUR FRACTURE 8 0.0003
782 HEART RATE DECREASED 9 0.0003
783 NEOPLASM MALIGNANT 17 0.0003
784 THERAPY CESSATION 13 0.0003
785 HEAD INJURY 8 0.0003
786 DIVERTICULITIS 7 0.0003
787 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
788 PREGNANCY 5 0.0002
789 MOVEMENT DISORDER 8 0.0002
790 VISION BLURRED 34 0.0002
791 PAIN IN JAW 7 0.0002
792 DEEP VEIN THROMBOSIS 16 0.0002
793 DISCOMFORT 15 0.0002
794 ANGINA PECTORIS 7 0.0002
795 NAUSEA 193 0.0002
796 OSTEONECROSIS 8 0.0002
797 PRODUCT SUBSTITUTION ISSUE 14 0.0002
798 MANIA 4 0.0002
799 OSTEONECROSIS OF JAW 6 0.0002
800 ARTHRITIS 19 0.0002
801 AGEUSIA 6 0.0002
802 DYSSTASIA 7 0.0002
803 SKIN DISCOLOURATION 11 0.0002
804 MOBILITY DECREASED 17 0.0002
805 THROMBOSIS 19 0.0002
806 FLUID RETENTION 12 0.0002
807 ANAPHYLACTIC SHOCK 6 0.0002
808 COUGH 65 0.0002
809 EMOTIONAL DISTRESS 28 0.0002
810 PRODUCTIVE COUGH 11 0.0002
811 DEVICE USE ISSUE 4 0.0002
812 VOMITING 107 0.0002
813 METASTASES TO LIVER 4 0.0002
814 HYPOGLYCAEMIA 11 0.0002
815 DYSPNOEA 128 0.0002
816 LETHARGY 13 0.0002
817 FALL 75 0.0002
818 SKIN EXFOLIATION 19 0.0002
819 GALLBLADDER DISORDER 4 0.0002
820 SYNOVITIS 4 0.0002
821 SURGERY 13 0.0002
822 DYSPHAGIA 21 0.0002
823 RESTLESS LEGS SYNDROME 4 0.0002
824 BALANCE DISORDER 19 0.0002
825 ARTHRALGIA 91 0.0002
826 MUSCLE SPASMS 40 0.0002
827 CHEST PAIN 40 0.0002
828 CONJUNCTIVITIS 4 0.0002
829 SWELLING FACE 14 0.0002
830 PAIN IN EXTREMITY 63 0.0002
831 SWELLING 20 0.0002
832 RASH 93 0.0002
833 PHOTOPHOBIA 4 0.0002
834 OSTEOARTHRITIS 9 0.0002
835 STAPHYLOCOCCAL INFECTION 7 0.0002
836 HEART RATE INCREASED 21 0.0002
837 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
838 VISUAL ACUITY REDUCED 7 0.0002
839 SKIN DISORDER 7 0.0002
840 INCREASED APPETITE 4 0.0002
841 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
842 CONFUSIONAL STATE 33 0.0002
843 ABDOMINAL DISCOMFORT 34 0.0002
844 URINARY INCONTINENCE 6 0.0002
845 DISORIENTATION 8 0.0002
846 NEOPLASM PROGRESSION 7 0.0002
847 PAIN 122 0.0002
848 LACRIMATION INCREASED 6 0.0002
849 LIMB DISCOMFORT 6 0.0002
850 MALAISE 84 0.0002
851 CARDIO-RESPIRATORY ARREST 8 0.0002
852 ROAD TRAFFIC ACCIDENT 8 0.0002
853 CEREBROVASCULAR ACCIDENT 32 0.0002
854 CYSTITIS 6 0.0002
855 PALPITATIONS 22 0.0002
856 TREMOR 31 0.0002
857 PRODUCT USE ISSUE 35 0.0002
858 PAIN OF SKIN 5 0.0002
859 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
860 MENTAL DISORDER 8 0.0002
861 DIZZINESS 91 0.0002
862 RESPIRATORY ARREST 5 0.0002
863 VERTIGO 11 0.0002
864 HEADACHE 113 0.0002
865 INSOMNIA 48 0.0002
866 STEVENS-JOHNSON SYNDROME 4 0.0002
867 URINARY RETENTION 6 0.0002
868 GAIT INABILITY 6 0.0002
869 ORAL PAIN 4 0.0002
870 GASTROINTESTINAL DISORDER 16 0.0002
871 BLISTER 10 0.0002
872 EYE PAIN 10 0.0002
873 DRUG INTOLERANCE 17 0.0002
874 HALLUCINATION 13 0.0002
875 DRY SKIN 23 0.0002
876 BLINDNESS 7 0.0002
877 LABORATORY TEST ABNORMAL 5 0.0002
878 PRODUCT PRESCRIBING ERROR 4 0.0002
879 PRURITUS 64 0.0002
880 DIABETIC KETOACIDOSIS 4 0.0002
881 RECTAL HAEMORRHAGE 7 0.0002
882 ADVERSE EVENT 15 0.0002
883 ANXIETY 46 0.0002
884 EYE SWELLING 6 0.0002
885 PNEUMONIA ASPIRATION 4 0.0002
886 ANGIOEDEMA 7 0.0002
887 ALOPECIA 31 0.0002
888 JOINT SWELLING 19 0.0002
889 CHEST DISCOMFORT 16 0.0002
890 HIP FRACTURE 5 0.0002
891 URTICARIA 26 0.0002
892 RHINORRHOEA 10 0.0002
893 DIPLOPIA 4 0.0002
894 AMNESIA 10 0.0002
895 NASAL CONGESTION 9 0.0002
896 ECZEMA 8 0.0002
897 SPEECH DISORDER 8 0.0002
898 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
899 EAR INFECTION 4 0.0002
900 PRODUCT DOSE OMISSION ISSUE 44 0.0001
901 DRY MOUTH 12 0.0001
902 ANGER 5 0.0001
903 HYPERHIDROSIS 19 0.0001
904 WEIGHT INCREASED 33 0.0001
905 SEIZURE 17 0.0001
906 MOOD ALTERED 4 0.0001
907 SKIN LESION 4 0.0001
908 MEDICATION ERROR 8 0.0001
909 NECK PAIN 8 0.0001
910 DEMENTIA 4 0.0001
911 LOSS OF CONSCIOUSNESS 18 0.0001
912 DRY EYE 7 0.0001
913 HYPOACUSIS 6 0.0001
914 PRODUCT DOSE OMISSION 9 0.0001
915 MYOCARDIAL INFARCTION 24 0.0001
916 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
917 DYSPEPSIA 13 0.0001
918 CORONARY ARTERY DISEASE 4 0.0001
919 BRADYCARDIA 7 0.0001
920 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
921 ERYTHEMA 27 0.0001
922 SYNCOPE 13 0.0001
923 EMOTIONAL DISORDER 4 0.0001
924 CARDIAC DISORDER 12 0.0001
925 SLEEP DISORDER 9 0.0001
926 BLOOD GLUCOSE INCREASED 24 0.0001
927 HYPERSENSITIVITY 23 0.0001
928 LUNG NEOPLASM MALIGNANT 5 0.0001
929 BRONCHITIS 9 0.0001
930 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
931 PARAESTHESIA 18 0.0001
932 INTENTIONAL PRODUCT MISUSE 10 0.0001
933 FEELING HOT 7 0.0001
934 NASOPHARYNGITIS 21 0.0001
935 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
936 PROSTATE CANCER 9 0.0001
937 ADVERSE DRUG REACTION 10 0.0001
938 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
939 PANIC ATTACK 4 0.0001
940 ACCIDENTAL OVERDOSE 4 0.0001
941 RESTLESSNESS 4 0.0001
942 SOMNOLENCE 22 0.0001
943 FLUSHING 11 0.0001
944 DYSARTHRIA 4 0.0001
945 DEPRESSION 24 0.0001
946 EYE IRRITATION 6 0.0001
947 MUSCULOSKELETAL STIFFNESS 9 0.0001
948 DYSPHONIA 6 0.0001
949 ABNORMAL BEHAVIOUR 4 0.0001
950 DYSKINESIA 4 0.0001
951 ILLNESS 10 0.0001
952 ARTHROPATHY 5 0.0001
953 INFLUENZA LIKE ILLNESS 7 0.0001
954 WHEEZING 5 0.0001
955 OCULAR HYPERAEMIA 4 0.0001
956 SKIN BURNING SENSATION 6 0.0001
957 FEELING ABNORMAL 20 0.0001
958 DYSGEUSIA 6 0.0001
959 VISUAL IMPAIRMENT 10 0.0001
960 AGGRESSION 4 0.0001
961 ASTHMA 9 0.0001
962 ACNE 6 0.0001
963 SINUSITIS 8 0.0001
964 NERVOUSNESS 4 0.0001
965 SUICIDAL IDEATION 7 0.0001
966 DERMATITIS ATOPIC 4 0.0001
967 DEPRESSED MOOD 4 0.0001
968 PRODUCT QUALITY ISSUE 10 0.0001
969 NO ADVERSE EVENT 13 0.0001
970 BURNING SENSATION 5 0.0001
971 CONVULSION 4 0.0001
972 OVERDOSE 15 0.0001
973 PSORIASIS 9 0.0001
974 HOT FLUSH 5 0.0001
975 MEMORY IMPAIRMENT 9 0.0001
976 DRUG DOSE OMISSION 10 0.0001
977 DEVICE MALFUNCTION 4 0.0001
978 DEVICE ISSUE 5 0.0001
979 AGITATION 4 0.0001
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
981 RHEUMATOID ARTHRITIS 6 0.0001
982 INJECTION SITE ERYTHEMA 6 0.0000
983 PRODUCT STORAGE ERROR 4 0.0000
984 BREAST CANCER 4 0.0000
985 MIGRAINE 4 0.0000
986 INCORRECT DOSE ADMINISTERED 8 0.0000
987 INJECTION SITE PAIN 7 0.0000